VERVE THERAPEUTICS INC's ticker is VERV and the CUSIP is 92539P101. A total of 74 filers reported holding VERVE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,547,415 | +114.0% | 116,698 | +202.7% | 0.01% | +120.0% |
| Q2 2023 | $722,945 | -70.2% | 38,557 | -77.1% | 0.01% | -66.7% |
| Q1 2023 | $2,424,377 | +119.3% | 168,126 | +194.3% | 0.02% | +150.0% |
| Q4 2022 | $1,105,311 | +59.5% | 57,122 | +183.0% | 0.01% | +50.0% |
| Q3 2022 | $693,000 | -64.0% | 20,186 | -84.0% | 0.00% | -66.7% |
| Q2 2022 | $1,927,000 | +245.3% | 126,129 | +415.5% | 0.01% | +140.0% |
| Q1 2022 | $558,000 | +85.4% | 24,466 | +281.9% | 0.01% | +25.0% |
| Q3 2021 | $301,000 | +1333.3% | 6,406 | +1725.1% | 0.00% | – |
| Q2 2021 | $21,000 | – | 351 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alphabet Inc. | 10,974,011 | $515,778,000 | 12.24% |
| Casdin Capital, LLC | 3,038,167 | $142,794,000 | 3.55% |
| Redmile Group, LLC | 1,869,030 | $87,844,000 | 1.53% |
| Logos Global Management LP | 443,265 | $20,833,000 | 1.50% |
| Novo Holdings A/S | 600,000 | $28,200,000 | 1.46% |
| Cormorant Asset Management, LP | 709,224 | $32,667,000 | 1.33% |
| Rock Springs Capital Management LP | 962,826 | $45,253,000 | 0.95% |
| HighVista Strategies LLC | 18,782 | $883,000 | 0.58% |
| RA Capital Management | 880,284 | $41,373,000 | 0.57% |
| Nicholas Investment Partners, LP | 132,300 | $6,218,000 | 0.45% |